HOSPIRA, INC. for HOSPIRA INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R.2725 FDA Safety Over Sequestration Act of 2013; S.1244 FY14 FDA Appropriations bill relating to sequestered user fees; S.1413 FDA User Fee Protection Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL DOWELL | — |
| JULIANA REED | — |
Health Issues HCR
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013; H.R.3204 The Drug Quality and Safety Act; Issues relating to prescription drug shortages; P.L. 111-148 Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S.232 Medical Device Access and Innovation Protection Act; S.957 The Drug Supply Chain of Security Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL DOWELL | — |
| JULIANA REED | — |
Pharmacy PHA
H.R.3204 The Compounding Clarity Act; S.959 The Pharmaceutical Quality, Security and Accountability Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL DOWELL | — |
| JULIANA REED | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.